OpenVSafe by OpenVAERS
Search V-safe

6N3-29246-68215

4 vaccinations 14 coded responses 37 check-ins 14 free-text entries 0 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
483 / MI
Registered
2021-03-09
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-07
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-09
    Registered in v-safe
  3. 2021-03-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  4. 2021-03-10
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site pain, Musculoskeletal stiffness — Feeling: Good · Muscle or body aches
    Free text: Still some soreness and muscle stiffness near injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-14
    Survey response — day 7, dose 1
    MedDRA: Epistaxis, Rash macular, Self-medication — Feeling: Good · Site: Redness · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Local red blotch on hand after minor scrape (uncharacteristic reaction for me) and unprovoked vigorous nosebleed, stopped after 20 minutes of packing, compression, and decongestant spray
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-21
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-03-28
    Dose 2 — Pfizer-BioNTech
  11. 2021-03-28
    Survey response — day 0, dose 2
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good
    Free text: Still having more nosebleeds than usual after 1st shot
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-03-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Epistaxis — Feeling: Good · Site: Pain
    Free text: Unprompted nosebleed
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-03-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Epistaxis, Rash, Vaccine positive rechallenge — Feeling: Good · Site: Pain, Redness · Headache, Muscle or body aches
    Free text: Getting some temporary red blotches on forehead that go away after a few hours. Noticed after first shot too. Also nosebleeds.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Epistaxis — Feeling: Good
    Free text: Nosebleed
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site erythema, Injection site pain — Feeling: Good · Site: Pain
    Free text: Still slight redness, soreness at injection site. But less soreness than after first shot.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  17. 2021-04-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Fatigue — Feeling: Good
    Free text: Plenty of sleep but still tired, fatigued with exertion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-04-04
    Survey response — day 7, dose 2
    MedDRA: Epistaxis — Feeling: Good
    Free text: Nosebleed
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-04-11
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-04-18
    Survey response — day 21, dose 2
    MedDRA: Epistaxis, Memory impairment, Sinus congestion — Feeling: Fair
    Free text: A couple severe nosebleeds that took more than 45 minutes to get under control. Some sinus congestion. Increased forgetfulness.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-25
    Survey response — day 28, dose 2
    MedDRA: Epistaxis, Fatigue — Feeling: Fair
    Free text: Having more fatigue. Also harder to stop nose bleeds.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-05-02
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  23. 2021-05-10
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-09-03
    Dose 3 — Pfizer-BioNTech
  25. 2021-09-04
    Survey response — days 1–6 daily, dose 3
    MedDRA: Epistaxis — Feeling: Fair · Site: Itching · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Vigorous nosebleed, used nasal decongestant spray, BleedCease packing, and compression to staunch flow.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  26. 2021-09-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  27. 2021-09-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache, Joint pains, Muscle or body aches
    Adult check-in
  28. 2021-09-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache, Nausea
    Adult check-in
  29. 2021-09-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache
    Adult check-in
  30. 2021-09-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  31. 2021-09-10
    Survey response — day 7, dose 3
    MedDRA: Epistaxis — Feeling: Good · Headache, Fatigue or tiredness
    Free text: Still having nosebleeds.
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-09-18
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-09-24
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  34. 2021-10-01
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-10-08
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-10-15
    Survey response — day 42, dose 3
    MedDRA: Headache, Unevaluable event — Feeling: Good
    Free text: Mild headaches occasionally in spite of being well hydrated.
    MedDRA releases: 2024-11 · check-in free text available
  37. 2021-12-03
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  38. 2022-03-04
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-03-25
    Dose 4 — Pfizer-BioNTech
  40. 2022-06-26
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  41. 2022-09-25
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in
  42. 2023-03-25
    Health check-in — 12 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-07Pfizer-BioNTech
22021-03-28Pfizer-BioNTech
32021-09-03Pfizer-BioNTech No
42022-03-25Pfizer-BioNTech No

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-10

Systemic reaction (other): Still some soreness and muscle stiffness near injection site

Release 5 — day 7, dose 1

2021-03-14

Systemic reaction (other): Local red blotch on hand after minor scrape (uncharacteristic reaction for me) and unprovoked vigorous nosebleed, stopped after 20 minutes of packing, compression, and decongestant spray

Release 6 — day 0, dose 2

2021-03-28

Systemic reaction (other): Still having more nosebleeds than usual after 1st shot

Release 6 — days 1–6 daily, dose 2

2021-03-29

Systemic reaction (other): Unprompted nosebleed

2021-03-30

Systemic reaction (other): Getting some temporary red blotches on forehead that go away after a few hours. Noticed after first shot too. Also nosebleeds.

2021-03-31

Systemic reaction (other): Nosebleed

2021-04-01

Systemic reaction (other): Still slight redness, soreness at injection site. But less soreness than after first shot.

2021-04-03

Systemic reaction (other): Plenty of sleep but still tired, fatigued with exertion

Release 6 — day 7, dose 2

2021-04-04

Systemic reaction (other): Nosebleed

Release 7 — day 21, dose 2

2021-04-18

Symptoms: A couple severe nosebleeds that took more than 45 minutes to get under control. Some sinus congestion. Increased forgetfulness.

Release 7 — day 28, dose 2

2021-04-25

Symptoms: Having more fatigue. Also harder to stop nose bleeds.

Release 9 — days 1–6 daily, dose 3

2021-09-04

Systemic reaction (other): Vigorous nosebleed, used nasal decongestant spray, BleedCease packing, and compression to staunch flow.

Release 9 — day 7, dose 3

2021-09-10

Systemic reaction (other): Still having nosebleeds.

Release 10 — day 42, dose 3

2021-10-15

Symptoms: Mild headaches occasionally in spite of being well hydrated.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDEpistaxis ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache · · ✓
SDMemory impairment ✓ ✓ ✓
SDSinus congestion ✓ ✓ ✓
SDUnevaluable event · · ✓
SROCondition aggravated ✓ ✓ ✓
SROEpistaxis ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROInjection site erythema ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SROMusculoskeletal stiffness ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SRORash ✓ ✓ ✓
SRORash macular ✓ ✓ ✓
SROSelf-medication ✓ ✓ ✓
SROVaccine positive rechallenge ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release